Web Results

pulmonaryfibrosisnews.com/2020/01/03/top-10-pulmonary-fibrosis-stories-of-2019

Jan 3, 2020 ... ... (AI) and machine learning to aid the development of new medicines for idiopathic pulmonary fibrosis (IPF) and chronic kidney disease (CKD).

www.rbht.nhs.uk/research/research-news-and-events/new-drug-shows-early-promise-clinical-trial-patients-ipf

This particular clinical trial, known as FLORA, was a randomised, double-blind, placebo-controlled trial investigating the drug GLPG1690, which was developed  ...

www.atsjournals.org/doi/full/10.1164/rccm.201903-0592PP

Mar 11, 2019 ... Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a ... in the early phases of new drug development and preferably starting early ...

www.future-science.com/doi/10.4155/fmc-2019-0111

Oct 21, 2019 ... However, drug discovery to prevent or revert IPF has been insufficient to cope with the development. Drug discovery targeting multiple links ...

www.researchgate.net/figure/The-timeline-from-discovery-to-clinical-application-of-three-IPF-drugs-The-pathway-from_fig1_272093156

Since the cost of drug development is so enormous, it would be most advantageous if clinical researchers in the near future could develop markers of therapeutic ...

www.nationaljewish.org/conditions/medications/ipf-medications

Sep 1, 2017 ... It is a triple kinase inhibitor that blocks several pathways that lead to the development of fibrosis. Like pirfenidone, nintedanib slows the ...

www.hindawi.com/journals/bmri/2015/329481

Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5-year survival ... of multiple tyrosine kinases originally developed as an anticancer drug , is a ...

www.ipstherapeutique.com/tag/ipf

Q. You recently attended the 3rd Annual IPF Summit in San Diego. ... was “ Overcome Translational Challenges in the Development of Truly Curative IPF Drugs”.

www.glpg.com/IPF

The ISABELA program is intended to support both New Drug Application ... a first- in-class autotaxininhibitor in clinical development for the treatment of IPF at ...

www.tandfonline.com/doi/abs/10.3402/ecrj.v2.26385

The strategy for drug development and the timeline from the discovery to the clinical use ... A better understanding of the molecular mechanisms of IPF as well as ...